O-21: Phenotyping and variability in obstructive sleep apnea: Implications for cardiovascular risk and personalized management
-
Register
- Non-member - $100
- Regular Member - $100
- Student Member - $100
- Technician Member - $100
To access the session recording, navigate to the content tab and click the view video button.
Session Schedule
Find a specific presentation in the session by navigating to the timestamp indicated below
0:00:00
Multi-night monitoring of variability in OSA severity and associated impacts on daytime impairment and quality of life
Simon Proctor (Australia)
0:12:35
Data-Driven Identification of OSA Subtypes through Endotypic Clustering in Multi-Cohort Population Studies
Sue Jung Lee (Korea, Republic of)
0:24:45
The combined effect of acetazolamide and oxygen (ACZO2) on OSA severity and endotypes
Shane Landry (Australia)
0:40:20
Respiratory self-similarity is a sleep apnea endotype that predicts cardiovascular disease related mortality in community-dwelling subjects
Yuenan Ni (China)
0:52:00
Sleep-stage dynamics predicts current sleep-disordered-breathing and future cardiovascular risk
Michal Bechny (Switzerland)
1:06:10
High night-to-night variability in OSA severity is associated with prevalent major adverse cardiovascular and cerebrovascular events
Bastien Lechat (Australia)